Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Japanese Surveillance Systems and Treatment for Influenza.

Zaraket H, Saito R.

Curr Treat Options Infect Dis. 2016;8(4):311-328. doi: 10.1007/s40506-016-0085-5. Epub 2016 Oct 10. Review.

2.

Peramivir injection in the treatment of acute influenza: a review of the literature.

Wester A, Shetty AK.

Infect Drug Resist. 2016 Aug 22;9:201-14. doi: 10.2147/IDR.S86460. eCollection 2016. Review.

3.

Influenza and the use of oseltamivir in children.

Çiftçi E, Karbuz A, Kendirli T.

Turk Pediatri Ars. 2016 Jun 1;51(2):63-71. doi: 10.5152/TurkPediatriArs.2016.2359. eCollection 2016 Jun. Review.

4.

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza.

Hurt AC, Kelly H.

Emerg Infect Dis. 2016 Jun;22(6):949-55. doi: 10.3201/eid2206.151037.

5.

Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.

Shinjoh M, Sugaya N, Yamaguchi Y, Tomidokoro Y, Sekiguchi S, Mitamura K, Fujino M, Shiro H, Komiyama O, Taguchi N, Nakata Y, Yoshida N, Narabayashi A, Myokai M, Sato M, Furuichi M, Baba H, Fujita H, Sato A, Ookawara I, Tsunematsu K, Yoshida M, Kono M, Tanaka F, Kawakami C, Kimiya T, Takahashi T, Iwata S; Keio Pediatric Influenza Research Group.

PLoS One. 2015 Aug 28;10(8):e0136539. doi: 10.1371/journal.pone.0136539. eCollection 2015.

6.

Prompt Oseltamivir Therapy Reduces Medical Care and Mortality for Patients With Influenza Infection: An Asian Population Cohort Study.

Wang CB, Chiu ML, Lin PC, Liang WM, Chen CY, Chang YJ, Wu TN, Wang JH, Sung FC.

Medicine (Baltimore). 2015 Jul;94(27):e1070. doi: 10.1097/MD.0000000000001070.

7.

Safety and efficacy of peramivir for influenza treatment.

Hata A, Akashi-Ueda R, Takamatsu K, Matsumura T.

Drug Des Devel Ther. 2014 Oct 24;8:2017-38. doi: 10.2147/DDDT.S46654. eCollection 2014. Review.

8.

Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

Havers F, Thaker S, Clippard JR, Jackson M, McLean HQ, Gaglani M, Monto AS, Zimmerman RK, Jackson L, Petrie JG, Nowalk MP, Moehling KK, Flannery B, Thompson MG, Fry AM.

Clin Infect Dis. 2014 Sep 15;59(6):774-82. doi: 10.1093/cid/ciu422. Epub 2014 Jul 16.

9.

Neurological events related to influenza A (H1N1) pdm09.

Cárdenas G, Soto-Hernández JL, Díaz-Alba A, Ugalde Y, Mérida-Puga J, Rosetti M, Sciutto E.

Influenza Other Respir Viruses. 2014 May;8(3):339-46. doi: 10.1111/irv.12241. Review.

10.

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.

Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, Mcvernon J, Barr IG, Middleton D, Hurt AC.

J Antimicrob Chemother. 2014 Sep;69(9):2458-69. doi: 10.1093/jac/dku146. Epub 2014 May 19.

11.

Factors influencing the diagnostic accuracy of the rapid influenza antigen detection test (RIADT): a cross-sectional study.

Tanei M, Yokokawa H, Murai K, Sakamoto R, Amari Y, Boku S, Inui A, Fujibayashi K, Uehara Y, Isonuma H, Kikuchi K, Naito T.

BMJ Open. 2014 Jan 2;4(1):e003885. doi: 10.1136/bmjopen-2013-003885.

12.

Antivirals in the 2009 pandemic--lessons and implications for future strategies.

Berera D, Zambon M.

Influenza Other Respir Viruses. 2013 Nov;7 Suppl 3:72-9. doi: 10.1111/irv.12172. Review.

13.

The burden of seasonal and pandemic influenza in infants and children.

Ruf BR, Knuf M.

Eur J Pediatr. 2014 Mar;173(3):265-76. doi: 10.1007/s00431-013-2023-6. Epub 2013 May 10.

14.

Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.

Kitano M, Kodama M, Itoh Y, Kanazu T, Kobayashi M, Yoshida R, Sato A.

Antimicrob Agents Chemother. 2013 May;57(5):2286-94. doi: 10.1128/AAC.02324-12. Epub 2013 Mar 11.

15.

Evaluation of a new immunochromatographic assay for rapid identification of influenza A, B, and A(H1N1)2009 viruses.

Mitamura K, Kawakami C, Shimizu H, Abe T, Konomi Y, Yasumi Y, Yamazaki M, Ichikawa M, Sugaya N.

J Infect Chemother. 2013 Aug;19(4):633-8. doi: 10.1007/s10156-012-0533-1. Epub 2012 Dec 20.

16.

Reliability of a newly-developed immunochromatography diagnostic kit for pandemic influenza A/H1N1pdm virus: implications for drug administration.

Sasaki T, Kubota-Koketsu R, Takei M, Hagihara T, Iwamoto S, Murao T, Sawami K, Fukae D, Nakamura M, Nagata E, Kawakami A, Mitsubayashi Y, Ohno M, Uehara Y, Fukukawa T, Kanai Y, Kosaka M, Ikuta K.

PLoS One. 2012;7(11):e50670. doi: 10.1371/journal.pone.0050670. Epub 2012 Nov 30.

17.

Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.

Miller PE, Rambachan A, Hubbard RJ, Li J, Meyer AE, Stephens P, Mounts AW, Rolfes MA, Penn CR.

PLoS One. 2012;7(9):e43491. doi: 10.1371/journal.pone.0043491. Epub 2012 Sep 11.

18.

Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.

Chowell G, Viboud C, Simonsen L, Miller MA, Echevarría-Zuno S, González-León M, Aburto VH.

BMC Infect Dis. 2012 Apr 20;12:97.

19.

Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): a multicenter study in Korea.

Ko JH, Kim JH, Kang JH, Kim JH, Eun BW, Kim KH, Hong JY, Oh SH.

J Korean Med Sci. 2012 Apr;27(4):408-15. doi: 10.3346/jkms.2012.27.4.408. Epub 2012 Mar 21.

Supplemental Content

Support Center